Hemo Organic News

Hemo Organic Limited Reports Quarterly Loss and Receives Qualified Audit Opinion

Hemo Organic Limited posted a net loss of Rs. 8.08 lakhs for the quarter ended September 30, 2025, compared to a profit of Rs. 16.39 lakhs in the previous year quarter. The company's auditors issued a qualified opinion citing lack of balance confirmations for trade receivables and trade payables in the books of accounts.

Hemo Organic Limited Approves Q1 2025 Results, Schedules AGM, and Acknowledges Stock Exchange Penalty

Hemo Organic Limited's Board of Directors held a meeting on August 13, 2025, approving several key items. The Board approved unaudited standalone financial results for the quarter ended June 30, 2025, along with a Limited Review Report. The company also approved the draft Director's Report for financial year 2024-25 and scheduled its 33rd Annual General Meeting for September 29, 2025, to be held through video conferencing. Additionally, the Board acknowledged a penalty of ₹11,800 (inclusive of GST) imposed by the Stock Exchange under SEBI regulations, which was paid on June 18, 2025. The auditor's review report contained a qualified opinion due to lack of balance confirmation details for trade receivables and trade payables.